Effect of adjuvants and route of immunizations on the immune response to recombinant plague antigens

This publication has 24 references indexed in Scilit:

• Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague
  Protein Expression and Purification, 2006
• Protection against Aerosolized Yersinia pestis Challenge following Homologous and Heterologous Prime-Boost with Recombinant Plague Antigens
  Infection and Immunity, 2005
• Effect of homologous and heterologous prime–boost on the immune response to recombinant plague antigens
  Vaccine, 2005
• Flea-Borne Transmission Model To Evaluate Vaccine Efficacy against Naturally Acquired Bubonic Plague
  Infection and Immunity, 2004
• The Common Vaccine Adjuvant Aluminum Hydroxide Up-Regulates Accessory Properties of Human Monocytes via an Interleukin-4-Dependent Mechanism
  Infection and Immunity, 2001
• Monophosphoryl Lipid A (MPL) Formulations for the Next Generation of Vaccines
  Methods, 1999
• The Role of Th1 and Th2 Cells for Mucosal IgA Responsesa
  Annals of the New York Academy of Sciences, 1996
• CpG motifs in bacterial DNA trigger direct B-cell activation
  Nature, 1995
• Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues.
  The Journal of Experimental Medicine, 1993
• Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens
  Vaccine, 1988